Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Neff
S A Armstrong

Leukemia

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Leukemia|March 27, 2009
Chromatin maps, histone modifications and leukemiaT Neff, S A Armstrong
Leukemia|March 2, 2012
Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemiaB G Mar, L Bullinger, E Basu, et al.
Leukemia|November 6, 2013
KRas(G12D)-evoked leukemogenesis does not require β-cateninC E L Ng, A Sinha, A Krivtsov, et al.
Leukemia|September 14, 2007
MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessmentM C Stubbs, Y M Kim, A V Krivtsov, et al.
Leukemia|December 17, 2005
Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemiaR W Stam, M L den Boer, M M C J Passier, et al.
Leukemia|November 10, 2012
Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1lL Chen, A J Deshpande, D Banka, et al.
Leukemia|October 22, 2015
Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivoP Arreba-Tutusaus, T S Mack, L Bullinger, et al.
Leukemia|December 14, 2012
Cell of origin determines clinically relevant subtypes of MLL-rearranged AMLA V Krivtsov, M E Figueroa, A U Sinha, et al.
Leukemia|June 18, 2011
The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in miceA J Deshpande, A Rouhi, Y Lin, et al.
Leukemia|July 2, 2016
Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemiasK Wang, M Sanchez-Martin, X Wang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Leukemia|March 27, 2009
Chromatin maps, histone modifications and leukemiaT Neff, S A Armstrong
Leukemia|March 2, 2012
Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemiaB G Mar, L Bullinger, E Basu, et al.
Leukemia|November 6, 2013
KRas(G12D)-evoked leukemogenesis does not require β-cateninC E L Ng, A Sinha, A Krivtsov, et al.
Leukemia|September 14, 2007
MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessmentM C Stubbs, Y M Kim, A V Krivtsov, et al.
Leukemia|December 17, 2005
Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemiaR W Stam, M L den Boer, M M C J Passier, et al.
Leukemia|November 10, 2012
Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1lL Chen, A J Deshpande, D Banka, et al.
Leukemia|October 22, 2015
Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivoP Arreba-Tutusaus, T S Mack, L Bullinger, et al.
Leukemia|December 14, 2012
Cell of origin determines clinically relevant subtypes of MLL-rearranged AMLA V Krivtsov, M E Figueroa, A U Sinha, et al.
Leukemia|June 18, 2011
The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in miceA J Deshpande, A Rouhi, Y Lin, et al.
Leukemia|July 2, 2016
Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemiasK Wang, M Sanchez-Martin, X Wang, et al.
Pageof 1